# Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.

> **NCT03091556** · — · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Drug-Induced Liver Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03091556
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-25
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03091556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03091556, "Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT03091556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*